Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
Treatment While Unhoused: Providing MOUD to Populations Experiencing Homelessness
Time: 3PM - 4PM Eastern Time
Call for Proposals: 2024 Police, Treatment, and Community Collaborative (PTACC) International Deflection and Pre-arrest Diversion Summit
Proposals are now being accepted for the 2024 Police, Treatment, and Community Collaborative (PTACC) International Deflection and Pre-arrest Diversion Summit. All submissions must be uploaded by April 19, 2024 at 12:00 PM PDT in order to be...
PTACC 2024 INTERNATIONAL DEFLECTION & PRE-ARREST DIVERSION SUMMIT
Date: Oct 29 - Nov 1, 2024
Location: Seattle, WA
Integrating Addiction Medicine with Treatment Courts
Time: 10AM - 5PM Eastern Time
This 6-hour, live course provides the education needed for prescribing clinicians to strengthen skills in partnering with treatment court and advocating for patients who are involved in treatment court. The course will include didactive presentations, small group discussions, FAQs, and challenging case studies.
Implementing Community-Based Addiction Treatment
TIME: 12PM - 1PM Eastern Time
Different components of cognitive-behavioral therapy affect specific cognitive mechanisms
Abstract Psychological therapies are among the most effective treatments for common mental health problems—however, we still know relatively little about how exactly they improve symptoms. Here, we demonstrate the power of combining theory...
Elevating Addiction Treatment Skills and Practice through the Neurobiological Advances in Addiction
TIME: 10:00AM - 11:30AM Eastern Time
This event will explore the the neuroscience of addiction, the impact of policy and historical treatment approaches, and an exploration of the dynamics of stigma and discrimination as primary barriers to addiction care.
The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis
Abstract Background The prevalence of cannabis use disorders (CUDs) in people who use cannabis recreationally has been estimated at 22%, yet there is a dearth of literature exploring CUDs among people who use medicinal cannabis. We aimed to...
A telemedicine bridge clinic improves access and reduces cost for opioid use disorder care
Abstract Objective We evaluated the impact of a telemedicine bridge clinic on treatment outcomes and cost for patients with opioid use disorder. Telemedicine bridge clinics deliver low-barrier rapid assessment of patients with opioid use...
A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets
Abstract Ibogaine (IBO) is an atypical psychedelic with a complex mechanism of action. To date, the mechanisms that may underlie its anti-addictive effects are still not defined. This study aims to identify changes in gene expression...